Ruggiero Alistaire D, Key Chia-Chi Chuang, Kavanagh Kylie
Section on Comparative Medicine, Department of Pathology, Wake Forest University School of Medicine, Winston-Salem, NC, United States.
Section on Molecular Medicine, Department of Internal Medicine, Wake Forest University School of Medicine, Winston-Salem, NC, United States.
Front Nutr. 2021 Feb 17;8:625331. doi: 10.3389/fnut.2021.625331. eCollection 2021.
Over 650 million adults are obese (body mass index ≥ 30 kg/m) worldwide. Obesity is commonly associated with several comorbidities, including cardiovascular disease and type II diabetes. However, compiled estimates suggest that from 5 to 40% of obese individuals do not experience metabolic or cardiovascular complications. The existence of the metabolically unhealthy obese (MUO) and the metabolically healthy obese (MHO) phenotypes suggests that underlying differences exist in both tissues and overall systemic function. Macrophage accumulation in white adipose tissue (AT) in obesity is typically associated with insulin resistance. However, as plastic cells, macrophages respond to stimuli in their microenvironments, altering their polarization between pro- and anti-inflammatory phenotypes, depending on the state of their surroundings. The dichotomous nature of MHO and MUO clinical phenotypes suggests that differences in white AT function dictate local inflammatory responses by driving changes in macrophage subtypes. As obesity requires extensive AT expansion, we posit that remodeling capacity with adipose expansion potentiates favorable macrophage profiles in MHO as compared with MUO individuals. In this review, we discuss how differences in adipogenesis, AT extracellular matrix deposition and breakdown, and AT angiogenesis perpetuate altered AT macrophage profiles in MUO compared with MHO. We discuss how non-autonomous effects of remote organ systems, including the liver, gastrointestinal tract, and cardiovascular system, interact with white adipose favorably in MHO. Preferential AT macrophage profiles in MHO stem from sustained AT function and improved overall fitness and systemic health.
全球有超过6.5亿成年人肥胖(体重指数≥30kg/m²)。肥胖通常与多种合并症相关,包括心血管疾病和II型糖尿病。然而,综合估计表明,5%至40%的肥胖个体未出现代谢或心血管并发症。代谢不健康肥胖(MUO)和代谢健康肥胖(MHO)表型的存在表明,组织和整体系统功能存在潜在差异。肥胖时白色脂肪组织(AT)中巨噬细胞的积累通常与胰岛素抵抗相关。然而,作为可塑性细胞,巨噬细胞会对其微环境中的刺激做出反应,根据周围环境的状态改变其促炎和抗炎表型之间的极化。MHO和MUO临床表型的二分性质表明,白色AT功能的差异通过驱动巨噬细胞亚型的变化来决定局部炎症反应。由于肥胖需要大量的AT扩张,我们推测,与MUO个体相比,脂肪扩张时的重塑能力增强了MHO中有利的巨噬细胞特征。在这篇综述中,我们讨论了与MHO相比,MUO中脂肪生成、AT细胞外基质沉积和分解以及AT血管生成的差异如何使AT巨噬细胞特征持续改变。我们还讨论了包括肝脏、胃肠道和心血管系统在内的远端器官系统的非自主性效应如何在MHO中与白色脂肪产生有利的相互作用。MHO中优先的AT巨噬细胞特征源于持续的AT功能以及整体健康状况和系统健康的改善。